Related Experiment Videos
Insights
Streptokinase effectively restores arterial patency in acute occlusions, particularly when main and branch vessels are affected or surgery poses high risks. However, it is contraindicated after major surgery, with blood disorders, or neurological deficits.
Area of Science:
- Vascular Surgery
- Thrombolytic Therapy
Background:
- Acute arterial occlusion due to thrombosis or embolization presents a significant clinical challenge.
- Restoring blood flow is critical to prevent tissue ischemia and limb loss.
Purpose of the Study:
- To evaluate the safety and efficacy of streptokinase in restoring arterial patency.
- To define appropriate clinical scenarios for streptokinase use in vascular surgery.
Main Methods:
- Clinical assessment of patients with acute arterial occlusions.
- Administration of streptokinase for thrombolysis.
- Evaluation of treatment outcomes including arterial patency and surgical risks.
Main Results:
- Streptokinase demonstrated safety and efficacy in restoring patency of acutely occluded arteries.
- Effective in cases involving occlusion of both main conduits and branches.
- Beneficial for patients with concurrent medical problems increasing surgical risks.
Conclusions:
- Streptokinase is a valuable adjunct, not an antagonist, to arterial surgery and Fogarty catheter use.
- Recommended for specific patient populations with acute arterial occlusions, considering contraindications.
- Contraindicated in patients post-major surgery, with blood dyscrasias, or neurological deficits secondary to ischemia.
Abstract:
We believe that streptokinase is safe and effective in restoring the patency of arteries that have been acutely occluded by thrombosis or embolization. It should be used on those patients in whom the branches as well as the main conduits are occluded. It should also be used when the risks of surgery are great because of concurrent medical problems. Streptokinase should not be used after major surgery, in patients with blood dyscrasias, or when there are neurologic deficits secondary to the arterial ischemia. Streptokinase should not be considered as an antagonist to arterial surgery with the use of the Fogarty catheter but as an adjunct to the ever increasing armamentarium of the vascular surgeon.